• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妊娠的生理药代动力学模型:已发表模型的系统评价。

Physiologically Based Pharmacokinetic Modeling in Pregnancy: A Systematic Review of Published Models.

机构信息

Pediatric Pharmacology and Pharmacometrics Research Center, University Children's Hospital Basel, Basel, Switzerland.

Certara, Princeton, New Jersey, USA.

出版信息

Clin Pharmacol Ther. 2018 Dec;104(6):1110-1124. doi: 10.1002/cpt.1084. Epub 2018 May 6.

DOI:10.1002/cpt.1084
PMID:29633257
Abstract

During recent years there has been a surge in developing and applying physiologically based pharmacokinetic (PBPK) models in pregnant women to better understand and predict changes in drug pharmacokinetics throughout pregnancy. As a consequence, the number of publications focusing on pregnancy PBPK models has increased substantially. However, to date these models, especially across various platforms, have not been systematically evaluated. Hence, this review aims to assess published PBPK models in pregnancy used for therapeutic purposes.

摘要

近年来,人们在开发和应用基于生理学的药代动力学(PBPK)模型以更好地理解和预测整个妊娠期间药物药代动力学变化方面取得了突飞猛进的发展。因此,专注于妊娠 PBPK 模型的出版物数量大大增加。然而,迄今为止,这些模型,特别是在各种平台上,尚未得到系统评估。因此,本综述旨在评估用于治疗目的的已发表的妊娠 PBPK 模型。

相似文献

1
Physiologically Based Pharmacokinetic Modeling in Pregnancy: A Systematic Review of Published Models.妊娠的生理药代动力学模型:已发表模型的系统评价。
Clin Pharmacol Ther. 2018 Dec;104(6):1110-1124. doi: 10.1002/cpt.1084. Epub 2018 May 6.
2
Transporters in Drug Development: Scientific and Regulatory Considerations.药物研发中的转运体:科学和监管考虑因素。
Clin Pharmacol Ther. 2018 Nov;104(5):793-796. doi: 10.1002/cpt.1214. Epub 2018 Sep 30.
3
Predictive Performance of Physiologically-Based Pharmacokinetic Models in Predicting Drug-Drug Interactions Involving Enzyme Modulation.基于生理学的药代动力学模型预测涉及酶调节的药物相互作用的预测性能。
Clin Pharmacokinet. 2018 Oct;57(10):1337-1346. doi: 10.1007/s40262-018-0635-8.
4
Drug Dosing in Pregnant Women: Challenges and Opportunities in Using Physiologically Based Pharmacokinetic Modeling and Simulations.孕妇药物剂量:应用生理基于药代动力学模型和模拟的挑战与机遇。
CPT Pharmacometrics Syst Pharmacol. 2018 Feb;7(2):103-110. doi: 10.1002/psp4.12274. Epub 2018 Jan 31.
5
Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification.基于生理的药代动力学(PBPK)建模与模拟方法:对已发表模型、应用及模型验证的系统综述
Drug Metab Dispos. 2015 Nov;43(11):1823-37. doi: 10.1124/dmd.115.065920. Epub 2015 Aug 21.
6
Crosstalk of physiological pH and chemical pKa under the umbrella of physiologically based pharmacokinetic modeling of drug absorption, distribution, metabolism, excretion, and toxicity.在药物吸收、分布、代谢、排泄和毒性的基于生理的药代动力学模型的保护伞下,探讨生理 pH 值和化学 pKa 的相互作用。
Expert Opin Drug Metab Toxicol. 2021 Sep;17(9):1103-1124. doi: 10.1080/17425255.2021.1951223. Epub 2021 Jul 31.
7
Species extrapolation of life-stage physiologically-based pharmacokinetic (PBPK) models to investigate the developmental toxicology of ethanol using in vitro to in vivo (IVIVE) methods.利用体外到体内(IVIVE)方法,对基于生理的药代动力学(PBPK)模型的生命阶段进行物种外推,以研究乙醇的发育毒理学。
Toxicol Sci. 2015 Feb;143(2):512-35. doi: 10.1093/toxsci/kfu246. Epub 2014 Nov 18.
8
Evaluation of physiologically based models of pregnancy and lactation for their application in children's health risk assessments.评估基于生理学的妊娠和哺乳期模型在儿童健康风险评估中的应用。
Crit Rev Toxicol. 2003;33(2):137-211. doi: 10.1080/713611035.
9
Evaluation of the potential impact of pharmacokinetic differences on tissue dosimetry in offspring during pregnancy and lactation.孕期和哺乳期药代动力学差异对后代组织剂量测定潜在影响的评估。
Regul Toxicol Pharmacol. 2003 Aug;38(1):1-16. doi: 10.1016/s0273-2300(03)00047-3.
10
The assessment of drug safety for the fetus.胎儿药物安全性评估。
Int J Clin Pharm. 2020 Dec;42(6):1533-1536. doi: 10.1007/s11096-020-01132-y. Epub 2020 Sep 2.

引用本文的文献

1
Physiologically Based Pharmacokinetic Modeling to Predict Lamotrigine Exposure in Special Populations to Facilitate Therapeutic Drug Monitoring and Guide Dosing Regimens.基于生理的药代动力学建模以预测特殊人群中拉莫三嗪的暴露量,以促进治疗药物监测并指导给药方案。
Pharmaceuticals (Basel). 2025 Apr 27;18(5):637. doi: 10.3390/ph18050637.
2
Impact of Pregnancy on the Pharmacokinetics and Metabolism of Nicotinamide in Humans.妊娠对人体烟酰胺药代动力学和代谢的影响。
Clin Pharmacol Ther. 2024 Mar;115(3):556-564. doi: 10.1002/cpt.3146. Epub 2024 Jan 11.
3
The Application of a Physiologically Based Toxicokinetic Model in Health Risk Assessment.
基于生理学的毒代动力学模型在健康风险评估中的应用。
Toxics. 2023 Oct 21;11(10):874. doi: 10.3390/toxics11100874.
4
Pregnancy related hormones increase CYP3A mediated buprenorphine metabolism in human hepatocytes: a comparison to CYP3A substrates nifedipine and midazolam.妊娠相关激素可增加人肝细胞中细胞色素P450 3A(CYP3A)介导的丁丙诺啡代谢:与CYP3A底物硝苯地平和咪达唑仑的比较。
Front Pharmacol. 2023 Jul 5;14:1218703. doi: 10.3389/fphar.2023.1218703. eCollection 2023.
5
Mechanistic modeling of ophthalmic, nasal, injectable, and implant generic drug products: A workshop summary report.眼科、鼻内、注射和植入式仿制药产品的机制建模:研讨会总结报告。
CPT Pharmacometrics Syst Pharmacol. 2023 May;12(5):631-638. doi: 10.1002/psp4.12952. Epub 2023 Mar 20.
6
Considering developmental neurotoxicity in vitro data for human health risk assessment using physiologically-based kinetic modeling: deltamethrin case study. 考虑使用基于生理的动力学建模的体外人类健康风险评估中的发育神经毒性数据:溴氰菊酯案例研究。
Toxicol Sci. 2023 Mar 20;192(1):59-70. doi: 10.1093/toxsci/kfad007.
7
The MPRINT Hub Data, Model, Knowledge and Research Coordination Center: Bridging the gap in maternal-pediatric therapeutics research through data integration and pharmacometrics.MPRINT 中心数据、模型、知识和研究协调中心:通过数据集成和药物动力学研究弥合母婴治疗学研究的差距。
Pharmacotherapy. 2023 May;43(5):391-402. doi: 10.1002/phar.2765. Epub 2023 Jan 25.
8
Impact of pregnancy related hormones on drug metabolizing enzyme and transport protein concentrations in human hepatocytes.妊娠相关激素对人肝细胞中药物代谢酶和转运蛋白浓度的影响。
Front Pharmacol. 2022 Sep 21;13:1004010. doi: 10.3389/fphar.2022.1004010. eCollection 2022.
9
Evaluation of a rapid, generic human gestational dose model.快速通用的人体妊娠剂量模型评估。
Reprod Toxicol. 2022 Oct;113:172-188. doi: 10.1016/j.reprotox.2022.09.004. Epub 2022 Sep 16.
10
Maternal-Fetal Drug Development: An Industry Perspective.母体-胎儿药物研发:行业视角。
J Clin Pharmacol. 2022 Sep;62 Suppl 1(Suppl 1):S18-S29. doi: 10.1002/jcph.2124.